Arielis

Anavex awarded grant to fund clinical trial of Rett syndrome drug

Anavex awarded grant to fund clinical trial of Rett syndrome drug | MarketWatch | January 19, 2017
Business
Source: MarketWatch
January 19, 2017
Anavex Life Sciences Corp. will receive funding for a phase 2 trial of its Anavex 2-73 drug from the International Rett Syndrome Foundation to study the rare neurological disorder.

Read Full Story
Popular Articles